Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen

BACKGROUND: Hydroxychloroquine (HCQ) and azithromycin (AZT) have been proposed for COVID-19 treatment. Data available in the literature reported a potential increased risk of fatal arrhythmias under these therapies. The aim of this study was to assess the effects of these drugs on QT interval and ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardini, Andrea, Ciconte, Giuseppe, Negro, Gabriele, Rondine, Roberto, Mecarocci, Valerio, Viva, Tommaso, Santini, Francesca, de Innocentiis, Carlo, Giannelli, Luigi, Witkowska, Ewa, Locati, Emanuela Teresina, Castelvecchio, Serenella, Marrocco-Trischitta, Massimiliano M., Vicedomini, Gabriele, Menicanti, Lorenzo, Pappone, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501148/
https://www.ncbi.nlm.nih.gov/pubmed/32956782
http://dx.doi.org/10.1016/j.ijcard.2020.09.038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501148/
https://www.ncbi.nlm.nih.gov/pubmed/32956782
http://dx.doi.org/10.1016/j.ijcard.2020.09.038

Ejemplares similares